Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent…
SYN-004 (ribaxamase) delayed release drug product is a multi-particulate, hard capsule for oral delivery of a recombinant β-lactamase enzyme designed to degrade β-lactam antibiotics administered intravenously, and thus prevent colon…